Raptor Pharmaceutical Corp.
Period Ending Dec 31, 2013
Total Revenue 16,872
Cost of Revenue 1,653
Gross Profit 15,219
Operating Expenses
Research and Development 29,177
Sales, General and Admin. 37,948
Non-Recurring Items -
Other -
Operating Income (51,906)
Income From Continuing Operations
Add'l Income/Expense Items (10,679)
Earnings Before Interest and Tax (62,585)
Interest Expense 6,832
Earnings Before Tax (69,417)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (69,417)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (69,417)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (69,417)